Vise Technologies’s Halozyme HALO Stock Holding History

Vise Technologies’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$743K	Buy	9,499 +2,075	+28%	+$141K	0.01%	946
2026 Q1	$500K	Hold	7,424	–	–	0.01%	867
2025 Q4	$500K	Buy	+7,424	New	+$499K	0.01%	872

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Vise Technologies's HALO Position: Q2 2026 in Review

Vise Technologies increased its Halozyme (HALO) stake by 28% in Q2 2026, buying an estimated $141K and bringing the position to 9,499 shares worth $743K. The position accounts for 0.01% of the portfolio, ranked #946.

Vise Technologies first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Vise Technologies held 9,499 shares of Halozyme worth $743K as of Q2 2026.
Vise Technologies bought 2,075 Halozyme shares in Q2 2026, an estimated $141K.
Halozyme made up 0.01% of Vise Technologies's portfolio in Q2 2026, its #946 holding.
Vise Technologies first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.